None
Quote | Senseonics Holdings Inc. (NYSE:SENS)
Last: | $0.4429 |
---|---|
Change Percent: | 3.0% |
Open: | $0.4348 |
Close: | $0.43 |
High: | $0.445 |
Low: | $0.4251 |
Volume: | 944,328 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | Senseonics Holdings Inc. (NYSE:SENS)
SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS PR Newswire Eligible individuals in the U.S. will pay $99 out of pocket for each 6-month CGM system, offering each year of continuous glucose monitoring for just $200* PA...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced data from the Eversense ® Post Approval Study is to b...
Message Board Posts | Senseonics Holdings Inc. (NYSE:SENS)
Subject | By | Source | When |
---|---|---|---|
well, $SENS, has been on a mad dash | $5.95akadawson-m | investorshub | 12/15/2022 2:09:24 PM |
turning stone | turning stone | investorshub | 12/14/2022 8:29:55 PM |
If youre still in $CYDY, Im all ears. | $5.95akadawson-m | investorshub | 12/13/2022 11:57:42 PM |
Okay people TURNING STONE Bought A nice | turning stone | investorshub | 12/13/2022 11:54:19 PM |
I am. Just waiting for the next pop | leemalone2k3 | investorshub | 09/25/2022 11:53:11 AM |
News, Short Squeeze, Breakout and More Instantly...
Senseonics Holdings Inc. Company Name:
SENS Stock Symbol:
NYSE Market:
SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS PR Newswire Eligible individuals in the U.S. will pay $99 out of pocket for each 6-month CGM system, offering each year of continuous glucose monitoring for just $200* PA...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced data from the Eversense ® Post Approval Study is to b...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Oppenheimer Healthcare Me...